Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Glioblastoma 14Brain Neoplasms 12Glioma 11Astrocytoma 9Meningioma 7Central Nervous System Neoplasms 7Gliosarcoma 6Diffuse Intrinsic Pontine Glioma 6Recurrence 4Neurofibromatosis 2 4Tuberous Sclerosis 3Pheochromocytoma 3Paraganglioma 3Neuroma, Acoustic 3Rhabdomyosarcoma 2Oligodendroglioma 2Neurofibromatosis 1 2Neuroendocrine Tumors 2Neoplasms 2Hereditary Sensory and Autonomic Neuropathies 2von Hippel-Lindau Disease 1Zollinger-Ellison Syndrome 1Vestibulocochlear Nerve Diseases 1Tuberous Sclerosis 2 1Tongue Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Somatostatinoma 1Seizures 1Sarcoma 1Salivary Gland Neoplasms 1

Interventions

Filgrastim 13Temozolomide 9Carboplatin 7Peripheral Blood Stem Cell Transplantation 6Cyclophosphamide 5sargramostim 4Magnetic Resonance Spectroscopy 4Irinotecan 4Etoposide 4Topotecan 3Thiotepa 3Radiotherapy 3Oxaliplatin 3O(6)-benzylguanine 3Granulocyte Colony-Stimulating Factor 3Busulfan 3etoposide phosphate 2Vorinostat 2Vincristine 2Specimen Handling 2Psychiatric Rehabilitation 2Melphalan 2Ifosfamide 2Erlotinib Hydrochloride 2Cyproheptadine 2Cisplatin 2Carmustine 22-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 2veliparib 1trioctyl phosphine oxide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Familial ependymoma × Everolimus × CNS × Clear all
NCT03387020 2021-08-27

Ribociclib and Everolimus in Treating Children With Recurrent or Refractory Malignant Brain Tumors

Pediatric Brain Tumor Consortium

Phase 1 Completed
22 enrolled 16 charts
CNS

Familial ependymoma, Diffuse Intrinsic Pontine Glioma, Glioma, Medulloblastoma, Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡